Injections: Arthrosamid

Arthrosamid® is a next-generation hydrogel injection designed to relieve pain and improve function in patients with knee osteoarthritis. It works by enhancing the joint’s cushioning and reducing inflammation.

This non-surgical option is ideal for individuals looking to delay or avoid knee replacement surgery.

Key Benefits:

  • Minimally invasive
  • Long-term symptom control
  • Suitable for mild to moderate OA
Screenshot 2025-07-18 at 13.05.13

Introducing Arthrosamid® 

Arthrosamid® is a non-biodegradable injectable polyacrylamide hydrogel (2.5% iPAAG) implant consisting of 2.5% cross-linked polyacrylamide and 97.5% water. It is administered via a simple, one-step procedure performed under local anaesthesia by a qualified physician, such as an orthopaedic surgeon or rheumatologist — ensuring you’re in and out of the clinic the same day. Arthrosamid® is proven to maintain a significant, long-lasting reduction in knee OA pain— even five years post-treatment.

 How does Arthrosamid® work? 

Arthrosamid® is the first and only permanent injectable implant that integrates with the knee’s synovial tissue, forming a scaffold that softens and increases tissue elasticity. This leads to decreased joint stiffness, reduced pain, and improved knee function.

Proven Results

  • Over 20 years of research and development.
  • Safe and effectivefor its intended use, even five years post-treatment.
  • Around 1,200,000 syringes of 2.5% iPAAG have been made for human use.

Contact us

if you have any further questions do not hesitate to contact us

Alternatively, book through Doctify: